Alaunos therapeutics inc TCRT.US 總覽分析
美股醫療保健
(TCRT 無簡報檔)
TCRT 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分較低，若以價值投資為目標，已經有長期投資部位可能需陸續減碼
TCRT 近期報酬表現
-5.32%
Alaunos therapeutics inc
0.38%
同產業平均
-0.07%
S&P500
與 TCRT 同產業的標的表現
- ALMS Alumis inc價值 -趨勢 2 分波段 4 分籌碼 3 分股利 1 分查看更多
TCRT 公司資訊
Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The Company is focused on exploring strategic alternatives, including, but not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. Separately, the Company is evaluating several potential in-licensing opportunities in obesity, oncology and virology.